RxSight, Inc. Non Peo Neo Avg Total Comp Amt
RxSight, Inc. (RXST) reported Non Peo Neo Avg Total Comp Amt of $2.48 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-28.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-04-28
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $2.48M DEF 14A · filed 2026-04-28 |
| 2024-12-31 | $5.80M DEF 14A · filed 2026-04-28 |
| 2023-12-31 | $1.81M DEF 14A · filed 2026-04-28 |
| 2022-12-31 | $649.36K DEF 14A · filed 2026-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |